Biostage (BSTG) Misses Q2 EPS by 3c
Tweet
Share
E-mailGet Alerts BSTG Hot Sheet
Join SI Premium – FREE
Biostage (NASDAQ: BSTG) reported Q2 EPS of ($0.10), $0.03 worse than the analyst estimate of ($0.07).
For earnings history and earnings-related data on Biostage (BSTG) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
- Rein Therapeutics Inc. (RNTX) Tops Q2 EPS by 39c
- Star Equity Holdings (STRR) Misses Q2 EPS by 8c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
